PDF
Full
Outline
To observe the clinical effect of Viral Flu Prescription combined with external treatment by pressing needle in the treatment of acute viral upper respiratory tract infection.
This study included 200 patients with acute viral upper respiratory tract infection（admitted to the emergency department and fever clinic from October 2023 to March 2024），who were divided into observation group and control group by random number tablemethod.The control group（100 cases）received conventional treatment.The observation group（100 cases）were treated with Viral Flu Prescription and external treatment by pressing needle on the basis of the control group.The data of patients in each group was compared，including the treatmenteffect，the time of body temperature returned to be normal，the time of cough，sore throat and runny nose to disappear，adverse reactions and TCM symptom scores before and after treatment（fever，sore throat，drymouth，thirst，stream turbidity stuff，etc.）and the levels of serum amyloid A（SAA），tumor necrosis factor-α（TNF-α），interleukin-6（IL-6），interleukin-10（IL-10）and other inflammatory factors.
The total effective rate of the observation group（99.00%，99/100）was higher than that of the control group（93.00%，93/100）（P<0.05）.Compared with those in the control group，the time of body temperature to return to be normal，the time for cough，sore throat and runny nose to disappear were shorter in the observation group（P<0.05）.The adverse reaction rate of the control group and the observation group was lower（P>0.05）.Before treatment，TCM symptom scores（fever，sore throat，dry and thirsty mouth，runny nose，etc.），the levels of SAA levels，TNF-α，IL-6 and IL-10 were compared in both groups（P>0.05）.After treatment，these indexes in the observation group were better than those in the control group（P<0.05）.
Viral Flu Prescription combined with external treatment by pressing needle has good clinical effect in the treatment of acute viralupper respiratory tract infection，which can better improve the symptoms of patients，promote patients to recover faster，and the treatment is safe and reliable.
PDF
73
34
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62199257
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
